Seer (SEER) Total Current Liabilities (2020 - 2026)
Seer (SEER) recorded quarterly Total Current Liabilities of $10.2 million in Q1 2026, down 34.72% quarter-over-quarter from $15.7 million in Q4 2025, and down 22.38% on a YoY basis from $13.2 million in Q1 2025.
Seer (SEER) Total Current Liabilities (2020 - 2026) Analysis & Trends
Seer's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $10.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 22.38% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (down 22.38% YoY), while the FY2025 annual figure was $15.7 million, up 2.37% from the prior year.
- Total Current Liabilities was $10.2 million for Q1 2026 at Seer, down from $15.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $17.0 million in Q2 2024 to a low of $10.2 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $13.6 million across 5 years, with a median of $13.2 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities soared 79.82% in 2022, then plunged 30.83% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $12.6 million in 2022, then grew by 5.07% to $13.2 million in 2023, then increased by 15.93% to $15.3 million in 2024, then advanced by 2.37% to $15.7 million in 2025, then plunged by 34.72% to $10.2 million in 2026.
- The last three Total Current Liabilities figures came in at $10.2 million (Q1 2026), $15.7 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 72.86 Mn |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | 10.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.24 Mn |
| Dec 31, 2025 | 15.69 Mn |
| Sep 30, 2025 | 15.04 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 13.20 Mn |
| Dec 31, 2024 | 15.33 Mn |
| Sep 30, 2024 | 14.38 Mn |
| Jun 30, 2024 | 17.04 Mn |
| Mar 31, 2024 | 12.83 Mn |
| Dec 31, 2023 | 13.22 Mn |
| Sep 30, 2023 | 12.52 Mn |
| Jun 30, 2023 | 15.81 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 12.58 Mn |
| Sep 30, 2022 | 13.62 Mn |
| Jun 30, 2022 | 15.02 Mn |
| Mar 31, 2022 | 11.15 Mn |
| Dec 31, 2021 | 13.42 Mn |
| Sep 30, 2021 | 9.55 Mn |
| Jun 30, 2021 | 8.36 Mn |